HO840M3128557482
ABS ACHIEVER-ET
029HO18296
Mastitis Resistance
GEBV 26*APR| Herds | Daughters | Reliability | Proof | %RK |
|---|---|---|---|---|
| 76 | 475 | 94% | 106 | 95% |
| Proof | Weighting | |
|---|---|---|
| Clinical Mastitis in First Lactation: | 102 | 33% |
| Clinical Mastitis in Later Lactations: | 108 | 33% |
| Somatic Cell Score (Combined): | 105 | 33% |
| Breed Average: | 100 |
| Clinical Mastitis in Daughters | ||
|---|---|---|
| First Lactation | Later Lactations | |
| No. Herds | 64 | 58 |
| No. Daughters | 428 | 298 |
| % Healthy Daughters | 96% | 97% |
| Breed Average | 95% | 91% |
Somatic Cell Score
GEBV 26*APR| Herds | Daughters | Reliability | Proof | %RK |
|---|---|---|---|---|
| 211 | 979 | 99% | 105 | 86% |
Breed Average: 100
| First Lactation | Second Lactation | Third Lactation | |
|---|---|---|---|
| Weighting | 33% | 33% | 33% |
| Rating | 103 | 106 | 106 |
| Breed Average | 100 | 100 | 100 |
Metabolic Diseases
GEBV 26*APR| Expected % Healthy Daughters | |||||||
|---|---|---|---|---|---|---|---|
| Herds | Daughters | Reliability | Proof | %RK | 1st Lact. | Later Lact. | |
| Subclinical Ketosis | 298 | 873 | 96% | 97 | 35% | -1.5% | -2.2% |
| Clinical Ketosis | 34 | 126 | 83% | 93 | 13% | -2.5% | -2.3% |
| Displaced Abomasum | 46 | 96 | 76% | 98 | 43% | -0.9% | -0.6% |
| Metabolic Disease Resistance | 91% | 95 | 26% | ||||
Fertility Disorders
GEBV 26*APR| Expected % Healthy Daughters | |||||||
|---|---|---|---|---|---|---|---|
| Herds | Daughters | Reliability | Proof | %RK | 1st Lact. | Later Lact. | |
| Retained Placenta | 61 | 369 | 96% | 109 | 98% | +2.8% | +3.2% |
| Metritis | 26 | 200 | 96% | 108 | 98% | +3.7% | +2.8% |
| Cystic Ovaries | 46 | 167 | 95% | 107 | 93% | +2.1% | +3.8% |
Hoof Health
GEBV 26*APR| Herds | Daughters | Reliability | Proof | %RK | Index Weighting | Expected % Healthy Daughters |
|---|---|---|---|---|---|---|
| 21 | 156 | 95% | 96 | 46% | ||
| Digital Dermatitis | 96% | 103 | 85% | 34% | +3.7% | |
| Interdigital Dermatitis | 87% | 103 | 81% | 9% | +1.0% | |
| Heel Horn Erosion | 95% | 96 | 45% | 14% | -2.0% | |
| Sole Ulcer | 95% | 88 | 10% | 20% | -10.5% | |
| Toe Ulcer | 94% | 103 | 62% | 10% | +0.6% | |
| White Line Lesion | 94% | 95 | 21% | 8% | -2.4% | |
| Sole Hemorrhage | 94% | 91 | 11% | 3% | -4.8% | |
| Interdigital Hyperplasia | 87% | 105 | 85% | 2% | +2.0% | |
Calf Health
GEBV 26*APR| Herds | Daughters | Reliability | Proof | %RK | Expected % Healthy Daughters | |
|---|---|---|---|---|---|---|
| Respiratory Problems | 32 | 392 | 97% | 102 | 71% | +1.7 % |
| Diarrhea | 14 | 191 | 95% | 101 | 59% | +0.9 % |
| Calf Health | 96% | 102 | 69% | |||